Breakpoints

124 Folgen

1. #64 – Putting the Fun in Fungi: A Fun-guide to New Antifungals

   Vom: 23.9.2022
2. #63 – I Never Metapneumovirus that Required Antibiotics: Prevention & Treatment of Common Respiratory Viruses in Adults

   Vom: 16.9.2022
3. #62 – Novel TheraPOOtics: The Microbiome, C. difficile, and LBPs

   Vom: 26.8.2022
4. #61 – Dosing Consult: Linezolid Therapeutic Drug Monitoring

   Vom: 19.8.2022
5. #60 – Going MAD for Non-COVID ID Literature: A Year in Review LIVE from MAD-ID

   Vom: 22.7.2022
6. #59 – Resistance in Pseudomonas aeruginosa: Pearls and Perils

   Vom: 15.7.2022
7. #58 – We're Gonorrhea-valuate: Updates and Implementation of STI Treatment Guidelines

   Vom: 24.6.2022
8. #57 – Dosing Consult: Ceftriaxone

   Vom: 27.5.2022
9. #56 – Empiric Escalation: Gazing into the Crystal Ball for Multidrug-Resistant Gram-Negatives

   Vom: 15.4.2022
10. #55 – One World: Global Perspectives in Antimicrobial Stewardship

    Vom: 25.3.2022
11. #54 – Connecting with our Colleagues: COVID-19 Treatments in Community Pharmacies

    Vom: 18.3.2022
12. #53 – Abscessus and fortuitum and avium, Oh My!: Updates and Controversies in NTM Management

    Vom: 18.2.2022
13. #52 – A Conversation with the Authors of IDSA Guidance on Treatment of AmpC, CRAB, and Stenotrophomonas

    Vom: 28.1.2022
14. #51 – A Conversation with the Authors of IDSA Guidance on Treatment of ESBL, CRE, and DTR Pseudomonas

    Vom: 21.1.2022
15. #50 – Moving to the Algo-rhythm of IDWeek 2021: Highlights in SoMe and ASP

    Vom: 17.12.2021
16. #49 – A PGY-What Now? A Primer on ID Pharmacy Fellowships

    Vom: 3.12.2021
17. #48 – Aligning Goals: Antibiotics in End of Life Care

    Vom: 19.11.2021
18. #47 – A Nefarious Orchestra: Gram-Negative Resistance Mechanisms Part 2

    Vom: 29.10.2021
19. #46 – A Nefarious Orchestra: Gram-Negative Resistance Mechanisms Part 1

    Vom: 22.10.2021
20. #45 – Expectation vs. Reality: An Insider look at the OVERCOME and MERINO-2 trials

    Vom: 24.9.2021